Solid Biosciences Inc. (SLDB) — Stock Score Summary

Solid Biosciences Inc. (SLDB) has a MoatMap StockRank of 43/100 based on Quality (34/100), Value (38/100), and Momentum (57/100) factor scores. The current signal is HOLD. Solid Biosciences is a clinical-stage gene therapy developer. It is pre-revenue, highly speculative, and lacks the validated manufacturing scale or commercial pricing power of a high-quality compounder.

Solid Biosciences Inc. is a clinical-stage gene therapy company dedicated to developing transformative treatments for Duchenne muscular dystrophy (DMD). The company's competitive edge lies in its proprietary AAV-based gene therapy platform designed to deliver functional dystrophin to muscle cells, addressing the underlying cause of the disease. It operates as a highly specialized biotech player focused on a single, severe rare genetic disorder with significant unmet medical need.

Key Financial Metrics

Price$6.57
Market Cap$696M
P/E (Forward)-3.70
Price/Book1.90
Return on Equity-57.4%
Return on Invested Capital-90.0%
Debt/Equity5.52
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-111M

Solid Biosciences Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Solid Biosciences Inc.’s (SLDB) StockRank?
MoatMap’s StockRank for Solid Biosciences Inc. (SLDB) is 43/100, with a Hold signal. It is a composite of Quality (34), Value (38), and Momentum (57) factor ranks across MoatMap’s 19,000+ stock universe.
Does Solid Biosciences Inc. have an economic moat?
Solid Biosciences Inc. (SLDB) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Solid Biosciences Inc. a buy, hold, or sell?
MoatMap’s current signal for Solid Biosciences Inc. (SLDB) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Solid Biosciences Inc. in?
Solid Biosciences Inc. (SLDB) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSLDB deep dive reportAI ChampionsHow we score stocksSense-check another stock